AREG expressed on sEVs derived from Chronic Myeloid Leukaemia (CML) cell lines or patient serum is able to activate EGFR on stromal cells in an in vitro model of a bone marrow (BM) niche. This evidence concerns the gene EGFR and chronic myelogenous leukemia, BCR-ABL1 positive.